Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896207 · ClinicalTrials.gov registry record · Phase 1
Studying Different Formulations of SR13668 in Healthy Volunteers
A Phase 1 study of Healthy, no Evidence of Disease, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00896207: Completed Phase 1 study of Healthy, no Evidence of Disease, sponsored by National Cancer Institute (NCI).
NCT00896207 is a Phase 1 study of Healthy, no Evidence of Disease that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 20 participants, below the 175-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896207, a Phase 1 study of Healthy, no Evidence of Disease, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized early phase I trial is studying different formulations of SR13668 in healthy volunteers. Giving SR13668 may help doctors learn more about how SR13668 is used by the body. It is not yet known which formulation of SR13668 is most effectively used by the body.
Primary Outcome
The first stage will be used to compare fed vs. fasted diet effect on the pharmacokinetics parameters under formulation 1.
Conditions Studied
Interventions
- DRUG Akt inhibitor SR13668
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
What the finished NCT00896207 record still lists
NCT00896207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 175-participant average among 11 other Healthy, no Evidence of Disease trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Healthy, no Evidence of Disease appearing as the primary indexed condition, and to 1 intervention - of which Akt inhibitor SR13668 is the first listed.
NCT00896207 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00896207 about?
NCT00896207 is a clinical study titled "Studying Different Formulations of SR13668 in Healthy Volunteers". This randomized early phase I trial is studying different formulations of SR13668 in healthy volunteers. Giving SR13668 may help doctors learn more about how SR13668 is used by the body. It is not yet known which formulation of SR13668 is most effectively used by the body.
What is the current status of trial NCT00896207?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-06. Estimated completion is 2010-03.
What conditions does trial NCT00896207 study?
This clinical trial studies the following conditions: Healthy, no Evidence of Disease.
What interventions are being tested in trial NCT00896207?
The interventions under investigation include: Akt inhibitor SR13668 (DRUG).
Who is sponsoring clinical trial NCT00896207?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00896207 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy, no Evidence of Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00896207's enrollment target sits among peer trials
20 8th of 11 higher than 3 of 11 other Healthy, no Evidence of Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy, no Evidence of Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diindolylmethane in Healthy Volunteers
COMPLETED · Phase 1
-
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
COMPLETED · Phase 1
-
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
COMPLETED · Phase 1
-
Lycopene in Healthy Male Participants
COMPLETED · Phase 1
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
COMPLETED · Phase 1
-
A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia